Biosafety Cabinets Market - Industry Outlook & Forecast 2023-2028

Description

The global biological safety cabinet market is expected to grow at a CAGR of 7.36% from 2022-2028.

MARKET TRENDS & DRIVERS

The Growth in Technological Advancements

With huge advancements in the technology sector, the biosafety cabinet market is also being integrated with technologies that can help detect any leakages or failures of any part of the cabinets. Over the past years, there have been huge developments in the technological integration with these biosafety cabinets. Technological developments such as HEPA filtration systems can filter out 99.9% of the contaminants in the air. These systems have also been integrated with IOT, such as automotive systems shut down and alarm systems that will raise alarms if these systems observe any malfunction or failure of the exhaust systems.

Increased Risk of Communal Diseases

The world has recently witnessed the catastrophe that communicable diseases can cause through the Covid-19 virus. A disease that can be spread from one person to another through various ways, including contact with another person's blood and bodily fluids or breathing in airborne viruses, and being bitten by an insect carrying the pathogen or virus is called a communicable or infectious disease. These diseases can have a variety of severity ranging from asymptomatic (no symptoms) to severe to fatal. Some examples of communicable diseases are HIV, hepatitis A, B, and C, measles, salmonella, and blood-borne diseases. The biosafety cabinets are used in laboratories to study the organisms that transmit such diseases and could be the cause of the spread of communal diseases. Since these pathogens are infectious and can easily spread, utmost care must be taken to handle them. Hence biosafety cabinets are a must in such cases. These cabinets also allow the researchers to analyze the functioning and the process of infection that these organisms inflict.

Development in Biological Testing

The world is currently moving towards modernization and an advanced technological era. These advancements in technology have allowed chemical, biological, and microbiological testing. Further, these tests are conducted to understand and conduct analysis or research on the parameters of a product/subject. The subject in biological testing can be a human, dead or alive, animals and birds. Growing importance is given to biological testing as it is crucial in the early and timely diagnostics of infectious diseases and helps properly manage patients. Biological testing is carried out with substances that can harm the environment and humans, which can also potentially cause infections among them. Hence, such reasons are driving the growth of biological testing facilities across the globe, which will positively impact the biosafety cabinet market as they would be an integral part of the laboratories handling such samples.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT TYPE

The biosafety cabinets or biological safety cabinets are of three major types Class I, II, III. They are assigned to various classes based on the level of safety and protection offered and the level of biosafety measures it can operate. Class II is further sub-segmented into five subcategories. The sub-segments have advanced features such as HEPA filtration systems; they regulate airflow pressure and are safer than class I biosafety cabinets. Class II held most of the global biosafety cabinet market share as they are versatile and used across most facilities.

Segmentation by Product Type

Class I
Class II
- Class II A1
- Class II A2
- Class II B1
- Class II B2
- Class II C1
Class III

INSIGHTS BY END-USER

The global biological safety cabinet market is driven by the safety requirement when handling hazardous substances across various sectors, such as pharmaceutical and biopharmaceuticals, academic research institutes, and diagnostic laboratories. The biosafety cabinets play a critical role in these sectors, enabling them to carry out tests and procedures without contamination. Research institutes are of two types private and university. Both play a very important role in finding new drug compositions and new techniques for diagnostic purposes for various diseases. Pharmaceutical and biopharmaceutical sectors had the majority share of the global biosafety cabinet market, accounting for over 53%. The biotechnology sector is propelling the industry's growth as it is heavily involved with researching and developing therapeutic proteins and drugs through genetic engineering. This sector is important for integrating biology and technology to change or improve a component, or entire biological system, which can benefit human welfare or the industry.

Segmentation by End-User

Pharmaceutical & Biopharmaceutical Companies
Diagnostic Laboratories
Academic Research Institutes

INSIGHTS BY DISTRIBUTION CHANNEL

The global biosafety cabinet market by distribution channels segments as online and offline. The offline method is one of the oldest techniques that are in existence that is utilized to get a company's products to their potential customer. In 2022, the offline distribution channel had the highest global biosafety cabinet market share. Factors such as broader reach in areas that lack better connectivity and high consumer trust associated with touching and experiencing the quality of products are driving the growth of this segment. Further, the online distribution channel allows manufacturers and vendors to have multichannel campaigns across various channels, such as third-party retailers and direct websites. Online shopping entails online buying, mobile ordering, and digital media. High penetration rates of connectivity are expected to grow the online multichannel platforms' visibility during the forecasted period, thus increasing the online presence of the vendors.

Segmentation by Distribution Channel

Offline
Online

GEOGRAPHICAL ANALYSIS

North America holds the largest global biosafety cabinet market share, accounting for over 38% in 2022. The market is majorly driven by the presence of pharmaceutical, research, and development institutes and laboratories for diagnostic purposes. The region of North America majorly consists of developed countries, and the U.S. is the major contributor to their economy. According to Torreya, in 2020, U.S pharmaceutical companies raised USD 120.3 billion in Initial Public Offering, the highest in recent years. Such reasons are projected to propel the growth of biosafety cabinets in the region during the forecasted period.

Segmentation by Geography

North America
- The U.S.
- Canada
Europe
- Germany
- The U.K.
- France
- Italy
- Spain
APAC
- China
- Japan
- India
- Australia
Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
Latin America
- Brazil
- Mexico

COMPETITIVE LANDSCAPE

The global biosafety cabinet market needs to be more cohesive and have many national and international participants. These players have been continuously focusing on innovation and product differentiation techniques. They also rely on these factors to capture higher market shares. It is also expected that with more favorable financial and technological capabilities will be able to invent and launch products that are technologically integrated, which might threaten the products of their competitors and could make their products and services non-competitive.

Key Company Profiles

Thermo Fisher
Kewaunee Scientific
Esco Lifesciences Group

Other Prominent Vendors

The Baker Company
Azbil Group
NuAire
Labconco
Germfree Laboratories
Cruma
Suzhou Antai Airtech Co Ltd
Qingdao Haier Biomedical
Air Science
Berner International
Contained Air Solutions
Bioevopeak
Photon Cleantech Inc

KEY QUESTIONS ANSWERED:

1. How big is the biosafety cabinet market?
2. What is the growth rate of the global biosafety cabinet market?
3. Which region dominates the global biosafety cabinet market share?
4. What are the significant trends in the biosafety cabinet market?
5. Who are the key players in the global biosafety cabinet market?

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY PRODUCT TYPE
- 4.3.2 MARKET SEGMENTATION BY END-USER
- 4.3.3 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
- 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

6.1 OVERVIEW
- 6.1.1 GROWTH IN TECHNOLOGICAL ADVANCES
- 6.1.2 INCREASED RISK OF COMMUNICABLE DISEASES
- 6.1.3 DEVELOPMENT IN BIOLOGICAL TESTING
6.2 MARKET LANDSCAPE
- 6.2.1 PRODUCT TYPE
- 6.2.2 END-USER
- 6.2.3 COMPETITIVE LANDSCAPE

7 MARKET AT A GLANCE

8 INTRODUCTION

8.1 OVERVIEW
8.2 KEY FACTORS
8.3 BIOSAFETY LEVELS
- 8.3.1 BIOSAFETY LEVEL 1
- 8.3.2 BIOSAFETY LEVEL 2
- 8.3.3 BIOSAFETY LEVEL 3
- 8.3.4 BIOSAFETY LEVEL 4

9 MARKET OPPORTUNITIES & TRENDS

9.1 INCREASE IN RISK OF COMMUNICABLE DISEASES
9.2 INCREASE IN R&D INVESTMENTS IN PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY
9.3 INCREASE IN REVENUES OF PHARMACEUTICAL COMPANIES

10 MARKET GROWTH ENABLERS

10.1 REGULATION IN PLACE BY ORGANIZATIONS
10.2 RAPID DEVELOPMENT IN BIOLOGICAL TESTING
10.3 RAPID GROWTH IN TECHNOLOGICAL DEVELOPMENT

11 MARKET RESTRAINTS

11.1 FLUCTUATION IN PRICES OF RAW MATERIALS AND SUPPLY CHAIN
11.2 SHORTAGE OF SKILLED LABOR

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
- 12.3.1 THREAT OF NEW ENTRANTS
- 12.3.2 BARGAINING POWER OF SUPPLIERS
- 12.3.3 BARGAINING POWER OF BUYERS
- 12.3.4 THREAT OF SUBSTITUTES
- 12.3.5 COMPETITIVE RIVALRY

13 PRODUCT TYPE

13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 CLASS I
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 MARKET BY GEOGRAPHY
13.4 CLASS II
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 MARKET BY GEOGRAPHY
- 13.4.4 CLASS II A1
- 13.4.5 CLASS II A1 MARKET SIZE & FORECAST
- 13.4.6 CLASS II A1 MARKET BY GEOGRAPHY
- 13.4.7 CLASS II A2
- 13.4.8 CLASS II A2 MARKET SIZE & FORECAST
- 13.4.9 CLASS II A2 MARKET BY GEOGRAPHY
- 13.4.10 CLASS II B1
- 13.4.11 CLASS II B1 MARKET SIZE & FORECAST
- 13.4.12 CLASS II B1 MARKET BY GEOGRAPHY
- 13.4.13 CLASS II B2
- 13.4.14 CLASS II B2 MARKET SIZE & FORECAST
- 13.4.15 CLASS II B2 MARKET BY GEOGRAPHY
- 13.4.16 CLASS II C1
- 13.4.17 CLASS II C1 MARKET SIZE & FORECAST
- 13.4.18 CLASS II C1 MARKET BY GEOGRAPHY
13.5 CLASS III
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
- 13.5.3 MARKET BY GEOGRAPHY

14 END-USER

14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 MARKET BY GEOGRAPHY
14.4 DIAGNOSTIC TESTING & LABORATORIES
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 MARKET BY GEOGRAPHY
14.5 ACADEMIC RESEARCH INSTITUTES
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 MARKET BY GEOGRAPHY

15 DISTRIBUTION CHANNEL

15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 OFFLINE
- 15.3.1 MARKET OVERVIEW
- 15.3.2 DEALERS & DISTRIBUTION
- 15.3.3 SPECIALTY STORES
- 15.3.4 MARKET SIZE & FORECAST
- 15.3.5 MARKET BY GEOGRAPHY
15.4 ONLINE
- 15.4.1 MARKET OVERVIEW
- 15.4.2 DIRECT SALES
- 15.4.3 THIRD-PARTY SALES
- 15.4.4 MARKET SIZE & FORECAST
- 15.4.5 MARKET BY GEOGRAPHY

16 GEOGRAPHY

16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW

17 NORTH AMERICA

17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 PRODUCT TYPE
- 17.3.1 MARKET SIZE & FORECAST
17.4 CLASS II
- 17.4.1 CLASS II: MARKET SIZE & FORECAST
17.5 END-USER
- 17.5.1 MARKET SIZE & FORECAST
17.6 DISTRIBUTION CHANNEL
- 17.6.1 MARKET SIZE & FORECAST
17.7 KEY COUNTRIES
- 17.7.1 US: MARKET SIZE & FORECAST
- 17.7.2 CANADA: MARKET SIZE & FORECAST

18 EUROPE

18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 PRODUCT TYPE
- 18.3.1 MARKET SIZE & FORECAST
18.4 CLASS II
- 18.4.1 CLASS II: MARKET SIZE & FORECAST
18.5 END-USER
- 18.5.1 MARKET SIZE & FORECAST
18.6 DISTRIBUTION CHANNEL
- 18.6.1 MARKET SIZE & FORECAST
18.7 KEY COUNTRIES
- 18.7.1 GERMANY: MARKET SIZE & FORECAST
- 18.7.2 UK: MARKET SIZE & FORECAST
- 18.7.3 FRANCE: MARKET SIZE & FORECAST
- 18.7.4 ITALY: MARKET SIZE & FORECAST
- 18.7.5 SPAIN: MARKET SIZE & FORECAST

19 APAC

19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 PRODUCT TYPE
- 19.3.1 MARKET SIZE & FORECAST
19.4 CLASS II
- 19.4.1 CLASS II: MARKET SIZE & FORECAST
19.5 END-USER
- 19.5.1 MARKET SIZE & FORECAST
19.6 DISTRIBUTION CHANNEL
- 19.6.1 MARKET SIZE & FORECAST
19.7 KEY COUNTRIES
- 19.7.1 CHINA: MARKET SIZE & FORECAST
- 19.7.2 JAPAN: MARKET SIZE & FORECAST
- 19.7.3 INDIA: MARKET SIZE & FORECAST
- 19.7.4 AUSTRALIA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 PRODUCT TYPE
- 20.3.1 MARKET SIZE & FORECAST
20.4 CLASS II
- 20.4.1 CLASS II: MARKET SIZE & FORECAST
20.5 END-USER
- 20.5.1 MARKET SIZE & FORECAST
20.6 DISTRIBUTION CHANNEL
- 20.6.1 MARKET SIZE & FORECAST
20.7 KEY COUNTRIES
- 20.7.1 SAUDI ARABIA: MARKET SIZE & FORECAST
- 20.7.2 SOUTH AFRICA: MARKET SIZE & FORECAST
- 20.7.3 UAE: MARKET SIZE & FORECAST

21 LATIN AMERICA

21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 PRODUCT TYPE
- 21.3.1 MARKET SIZE & FORECAST
21.4 CLASS II
- 21.4.1 MARKET SIZE & FORECAST
21.5 END-USER
- 21.5.1 MARKET SIZE & FORECAST
21.6 DISTRIBUTION CHANNEL
- 21.6.1 MARKET SIZE & FORECAST
21.7 KEY COUNTRIES
- 21.7.1 BRAZIL: MARKET SIZE & FORECAST
- 21.7.2 MEXICO: MARKET SIZE & FORECAST

22 COMPETITIVE LANDSCAPE

22.1 COMPETITION OVERVIEW

23 KEY COMPANY PROFILES

23.1 THERMO FISHER
- 23.1.1 BUSINESS OVERVIEW
- 23.1.2 PRODUCT OFFERINGS
- 23.1.3 KEY STRATEGIES
- 23.1.4 KEY STRENGTHS
- 23.1.5 KEY OPPORTUNITIES
23.2 KEWAUNEE SCIENTIFIC
- 23.2.1 BUSINESS OVERVIEW
- 23.2.2 PRODUCT OFFERINGS
- 23.2.3 KEY STRATEGIES
- 23.2.4 KEY STRENGTHS
- 23.2.5 KEY OPPORTUNITIES
23.3 ESCO LIFESCIENCES GROUP
- 23.3.1 BUSINESS OVERVIEW
- 23.3.2 PRODUCT OFFERINGS
- 23.3.3 KEY STRATEGIES
- 23.3.4 KEY STRENGTHS
- 23.3.5 KEY OPPORTUNITIES

24 OTHER PROMINENT VENDORS

24.1 THE BAKER COMPANY
- 24.1.1 BUSINESS OVERVIEW
- 24.1.2 PRODUCT OFFERINGS
24.2 AZBIL GROUP
- 24.2.1 BUSINESS OVERVIEW
- 24.2.2 PRODUCT OFFERINGS
24.3 NUAIRE
- 24.3.1 BUSINESS OVERVIEW
- 24.3.2 PRODUCT OFFERINGS
24.4 LABCONCO
- 24.4.1 BUSINESS OVERVIEW
- 24.4.2 PRODUCT OFFERINGS
24.5 GERMFREE LABORATORIES
- 24.5.1 BUSINESS OVERVIEW
- 24.5.2 PRODUCT OFFERINGS
24.6 CRUMA
- 24.6.1 BUSINESS OVERVIEW
- 24.6.2 PRODUCT OFFERINGS
24.7 SUZHOU ANTAI AIRTECH CO LTD
- 24.7.1 BUSINESS OVERVIEW
- 24.7.2 PRODUCT OFFERINGS
24.8 QINGDAO HAIER BIOMEDICAL
- 24.8.1 BUSINESS OVERVIEW
- 24.8.2 PRODUCT OFFERINGS
24.9 AIR SCIENCE
- 24.9.1 BUSINESS OVERVIEW
- 24.9.2 PRODUCT OFFERINGS
24.10 BERNER INTERNATIONAL
- 24.10.1 BUSINESS OVERVIEW
- 24.10.2 PRODUCT OFFERINGS
24.11 CONTAINED AIR SOLUTIONS
- 24.11.1 BUSINESS OVERVIEW
- 24.11.2 PRODUCT OFFERING
24.12 BIOEVOPEAK
- 24.12.1 BUSINESS OVERVIEW
- 24.12.2 PRODUCT OFFERING
24.13 PHOTON CLEAN INC
- 24.13.1 BUSINESS OVERVIEW
- 24.13.2 PRODUCT OFFERING

25 REPORT SUMMARY

25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS

26 QUANTITATIVE SUMMARY

26.1 MARKET BY GEOGRAPHY
26.2 NORTH AMERICA
- 26.2.1 PRODUCT TYPE: MARKET SIZE & FORECAST
- 26.2.2 CLASS II: MARKET SIZE & FORECAST
- 26.2.3 END-USER: MARKET SIZE & FORECAST
- 26.2.4 DISTRIBUTION CHANNEL: MARKET SIZE & FORECAST
26.3 EUROPE
- 26.3.1 PRODUCT TYPE: MARKET SIZE & FORECAST
- 26.3.2 CLASS II: MARKET SIZE & FORECAST
- 26.3.3 END-USER: MARKET SIZE & FORECAST
- 26.3.4 DISTRIBUTION CHANNEL: MARKET SIZE & FORECAST
26.4 APAC
- 26.4.1 PRODUCT TYPE: MARKET SIZE & FORECAST
- 26.4.2 CLASS II: MARKET SIZE & FORECAST
- 26.4.3 END-USER: MARKET SIZE & FORECAST
- 26.4.4 DISTRIBUTION CHANNEL: MARKET SIZE & FORECAST
26.5 MIDDLE EAST & AFRICA
- 26.5.1 PRODUCT TYPE: MARKET SIZE & FORECAST
- 26.5.2 CLASS II: MARKET SIZE & FORECAST
- 26.5.3 END-USER: MARKET SIZE & FORECAST
- 26.5.4 DISTRIBUTION CHANNEL: MARKET SIZE & FORECAST
26.6 LATIN AMERICA
- 26.6.1 PRODUCT TYPE: MARKET SIZE & FORECAST
- 26.6.2 CLASS II: MARKET SIZE & FORECAST
- 26.6.3 END-USER: MARKET SIZE & FORECAST
- 26.6.4 DISTRIBUTION CHANNEL: MARKET SIZE & FORECAST

27 APPENDIX

27.1 ABBREVIATIONS